Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer

BACKGROUND: The purpose of this study was to evaluate the clinical impact of oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX-4) chemotherapy in terms of the response rate, progression-free/overall survival (PFS/OS) and safety profile in patients with heavily pretreated recurrent epithelial ovari...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Conteduca, Vincenza, Gurioli, Giorgia, Rossi, Lorena, Scarpi, Emanuela, Lolli, Cristian, Schepisi, Giuseppe, Farolfi, Alberto, De Lisi, Delia, Gallà, Valentina, Burgio, Salvatore Luca, Menna, Cecilia, Amadori, Andrea, Losi, Lorena, Amadori, Dino, Costi, Maria Paola, De Giorgi, Ugo
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2018
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6300035/
https://ncbi.nlm.nih.gov/pubmed/30567527
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5180-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars